We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
Cap. Flow
+$156M
Cap. Flow %
7.83%
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294

Top Buys

Rank Stock Value
1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$8.42M
2
MPC icon
Marathon Petroleum
MPC
+$5.47M
3
LBTYK icon
Liberty Global Class C
LBTYK
+$5.39M
4
ORLY icon
O'Reilly Automotive
ORLY
+$5.32M
5
CROX icon
Crocs
CROX
+$5.07M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$12.6M
2
TPR icon
Tapestry
TPR
+$12M
3
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$8.32M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$6.96M
5
SAGE
Sage Therapeutics
SAGE
+$6.93M

Sector Composition

Rank Sector Weight
1 Healthcare 2.95%
2 Consumer Discretionary 2.51%
3 Technology 1.96%
4 Energy 1.43%
5 Communication Services 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LBTYK icon
101
Liberty Global Class C
LBTYK
$3.53B
$5.57M 0.28%
+210,000
New +$5.39M
SAGE
102
CALL
DELISTED
Sage Therapeutics
SAGE
$5.51M 0.28%
+30,100
New +$5.14M
NVAX icon
103
CALL
Novavax
NVAX
$1.2B
$5.45M 0.27%
930,000
+828,920
+820% +$6.52M
AEM icon
104
Agnico Eagle Mines
AEM
$73.6B
$5.39M 0.27%
+105,300
New +$4.6M
VALE icon
105
CALL
Vale
VALE
$64.1B
$5.38M 0.27%
400,000
– –
INCY icon
106
CALL
Incyte
INCY
$24.2B
$5.33M 0.27%
62,800
+15,000
+31% +$1.2M
SRPT icon
107
PUT
Sarepta Therapeutics
SRPT
$1.57B
$5.32M 0.27%
35,000
+15,000
+75% +$1.82M
TJX icon
108
CALL
TJX Companies
TJX
$174B
$5.29M 0.27%
+100,000
New +$5.32M
GBT
109
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5.26M 0.26%
100,000
+80,000
+400% +$4.6M
ALXN
110
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
$5.24M 0.26%
+40,000
New +$5.16M
DKS icon
111
PUT
Dick's Sporting Goods
DKS
$17.5B
$5.2M 0.26%
+150,000
New +$5.49M
ORLY icon
112
O'Reilly Automotive
ORLY
$72.9B
$5.17M 0.26%
+210,000
New +$5.32M
ONCE
113
CALL
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$5.12M 0.26%
50,000
-60,000
-55% -$6.47M
ALNY icon
114
PUT
Alnylam Pharmaceuticals
ALNY
$27.5B
$5.04M 0.25%
+69,500
New +$5.33M
OXY icon
115
CALL
Occidental Petroleum
OXY
$56.8B
$5.03M 0.25%
+100,000
New +$5.63M
QURE icon
116
uniQure
QURE
$3.03B
$5.01M 0.25%
+64,069
New +$4.08M
SIX
117
PUT
DELISTED
Six Flags Entertainment Corp.
SIX
$4.97M 0.25%
100,000
-80,000
-44% -$4.13M
ESPR
118
CALL
DELISTED
Esperion Therapeutics
ESPR
$4.88M 0.25%
+105,000
New +$4.93M
IP icon
119
PUT
International Paper
IP
$21.6B
$4.87M 0.25%
+118,800
New +$5.03M
SFLY
120
CALL
DELISTED
Shutterfly, Inc.
SFLY
$4.83M 0.24%
+95,600
New +$4.37M
S
121
CALL
DELISTED
Sprint Corporation
S
$4.81M 0.24%
732,500
+432,500
+144% +$2.73M
RHT
122
PUT
DELISTED
Red Hat Inc
RHT
$4.7M 0.24%
25,000
– –
YUMC icon
123
PUT
Yum China
YUMC
$16.5B
$4.62M 0.23%
+100,000
New +$4.34M
VRTX icon
124
CALL
Vertex Pharmaceuticals
VRTX
$121B
$4.58M 0.23%
25,000
-10,000
-29% -$1.75M
VRTX icon
125
PUT
Vertex Pharmaceuticals
VRTX
$121B
$4.58M 0.23%
25,000
– –
3 4
5
6 7

Similar funds

ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Caption Management's Q2 2019 Portfolio in Review

As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.

By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.

  • Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
  • Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
  • Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
  • Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
  • Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
  • Caption Management opened 395 new positions and closed 294 in Q2 2019.
  • Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.

Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.